Impact of fixed-dose combination of germacrone, curdione, and furanodiene on breast cancer cell proliferation

Cell Journal

Volumn 15, Issue 2, 2013, Pages 160-165

  Kong, Qi ^a   Sun, Fangyun ^b   Chen, Xiuping ^c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b XIZANG MINZU UNIVERSITY   (China)

^c UNIVERSITY OF MACAU   (Macao)

Author keywords

Breast cancer; Chinese medicine; Fixed dose combination; Intra herbal drug interactions; Proliferation

Indexed keywords

BOK PROTEIN; CASPASE 9; CURDIONE; CYTOTOXIC AGENT; FURANODIENE; GERMACRONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; CURCUMA; CURCUMA WENYUJIN; DRUG EFFECT; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84901788025     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ernst E. Complementary and alternative medicine (CAM) and cancer: the kind face of complementary medicine. Int J Surg. 2009; 7(6): 499-500.
2. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs. 2010; 14(4): E45-55.
3. Sewitch MJ, Rajput Y. A literature review of complementary and alternative medicine use by colorectal cancer patients. Complement Ther Clin Pract. 2010; 16(1): 52-56.
4. van der Greef J, van Wietmarschen H, Schroen J, Wang M, Hankemeier T, Xu G. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Med. 2010; 76(17): 2036-2047.
5. Ma T, Tan C, Zhang H, Wang M, Ding W, Li S. Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol Biosyst. 2010; 6(4): 613-619.
6. Zhao J, Jiang P, Zhang W. Molecular networks for the study of TCM pharmacology. Brief Bioinform. 2010; 11(4): 417-430.
7. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 2008; 105(12): 4826-4831.
8. Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel. 2010; 13(1): 50-65.
9. Cheng CW, Fan W, Ko SG, Song L, Bian ZX. Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore (NY). 2010; 6(5): 324-329.
10. Huntley A. Drug-herb interactions with herbal medicines for menopause. J Br Menopause Soc. 2004; 10(4): 162-165.
11. Tomlinson B, Hu M, Lee VW. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Mol Nutr Food Res. 2008; 52(7): 799-809.
12. Chong S. The natural medicine Curcumaewenyujin 1. Beijing: People's Health Publishing House. 2008: 326.
13. Ma E, Wang X, Li Y, Sun X, Tai W, Li T, et al. Induction of apoptosis by furanodiene in HL60 leukemia cells through activation of TNFR1 signaling pathway. Cancer Lett. 2008; 271(1): 158-166.
14. Sun XY, Zheng YP, Lin DH, Zhang H, Zhao F, Yuan CS. Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin. Am J Chin Med. 2009; 37(3): 589-596.
15. Zhong Z, Chen X, Tan W, Xu Z, Zhou K, Wu T, et al. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2011; 667(1-3): 50-55.
16. Rui D, Xiaoyan C, Taixiang W, Guanjian L. Elemene for the treatment of lung cancer. Cochrane Database Syst Rev. 2007; 17(4): CD006054.
17. Yang FQ, Wang YT, Li SP. Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. J Chromatogr A. 2006; 1134(1-2): 226-231.
18. Chen X, Pei L, Zhong Z, Guo J, Zhang Q, Wang Y. Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine. 2011; 18(14): 1238-1243.
19. Chen X, Zhong Z, Xu Z, Chen L, Wang Y. No protective effect of curcumin on hydrogen peroxide-induced cytotoxicity in HepG2 cells. Pharmacol Rep. 2011; 63(3): 724-732.
20. Chen X, Zhang H, McAfee S, Zhang C. The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice. Am J Physiol Heart Circ Physiol. 2010; 299(3): H605-612.
21. Dancey JE, Chen HX. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat Rev Drug Discov. 2006; 5(8): 649-659.
22. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 2007; 3(7): 360-366.
23. Li S, Zhang B, Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol. 2011; 5 Suppl 1: S10.
24. Li S, Zhang B, Jiang D, Wei Y, Zhang N. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics. 2010; 11 Suppl 11: S6.
25. Ung CY, Li H, Cao ZW, Li YX, Chen YZ. Are herb-pairs of traditional Chinese medicine distinguishable from others? Pattern analysis and artificial intelligence classification study of traditionally defined herbal properties. J Ethnopharmacol. 2007; 111(2): 371-377.
26. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001; 8(5): 401-409.
27. Adams LS, Seeram NP, Hardy ML, Carpenter C, Heber D. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med. 2006; 3(1): 117-124.
28. Oh OJ, Min HY, Lee SK. Inhibition of inducible prostaglandin E2 production and cyclooxygenase-2 expression by curdione from Curcuma zedoaria. Arch Pharm Res. 2007; 30(10): 1236-1239.
29. Hou XL, Hayashi-Nakamura E, Takatani-Nakase T, Tanaka K, Takahashi K, Komatsu K, et al. Curdione Plays an Important Role in the Inhibitory Effect of Curcuma aromatica on CYP3A4 in Caco-2 Cells. Evid Based Complement Alternat Med. 2011; 2011: 913898.
30. Hsu SY, Kaipia A, McGee E, Lomeli M, Hsueh AJ. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA. 1997; 94(23): 12401-12406.
31. Zhang L, Insel PA. The Pro-apoptotic Protein Bim Is a Convergence Point for cAMP/Protein Kinase A- and Glucocorticoid-promoted Apoptosis of Lymphoid Cells. J Biol Chem. 2004; 279(20): 20858-20865.